Brain Tumor Diagnosis and Targeted Therapy
A special issue of Journal of Personalized Medicine (ISSN 2075-4426). This special issue belongs to the section "Personalized Therapy and Drug Delivery".
Deadline for manuscript submissions: closed (29 February 2024) | Viewed by 235
Special Issue Editor
2. Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA
Interests: brain tumors; tumor microenvironment; miRNAs; molecular therapies; cancer stem cells; epigenetics; nanomedicine; cellular transitions
Special Issue Information
Dear Colleagues,
Despite our progress in the molecular understanding of brain tumor biology, translating these advances has remained a challenge in the field. As the brain tumor space keeps evolving to leverage new knowledge generated by cutting-edge technologies, including single-cell transcriptomics, advances in spatially resolved approaches, and innovations in nano-carriers and drug-delivery technology, we can expect to see creative solutions being developed to diagnose and treat brain tumors. This Special Issue aims to highlight forward thinking points of view on how to move the field forward as well as showcase innovative research approaches aimed at improving diagnosis and therapy for brain tumors.
Dr. Hernando Lopez-Bertoni
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Personalized Medicine is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- brain tumors
- glioma
- glioblastoma
- tumor microenvironment
- novel markers of gliomas
- targeted therapies
- resistance and recurrence
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
